These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 25378970)
1. Appropriate candidates for statin use in heart failure. Seo HS Korean J Intern Med; 2014 Nov; 29(6):730-4. PubMed ID: 25378970 [No Abstract] [Full Text] [Related]
2. Effects of intensive versus mild lipid lowering by statins in patients with ischemic congestive heart failure: Korean Pitavastatin Heart Failure (SAPHIRE) study. Lee HY; Cho HJ; Kim HY; Jeon HK; Shin JH; Kang SM; Baek SH Korean J Intern Med; 2014 Nov; 29(6):754-63. PubMed ID: 25378974 [TBL] [Abstract][Full Text] [Related]
3. Prognostic Impact of Statin Intensity in Heart Failure Patients With Ischemic Heart Disease: A Report From the CHART-2 (Chronic Heart Failure Registry and Analysis in the Tohoku District 2) Study. Oikawa T; Sakata Y; Nochioka K; Miura M; Tsuji K; Onose T; Abe R; Kasahara S; Sato M; Shiroto T; Takahashi J; Miyata S; Shimokawa H; J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29540427 [TBL] [Abstract][Full Text] [Related]
4. Pitavastatin shows greater lipid-lowering efficacy over 12 weeks than pravastatin in elderly patients with primary hypercholesterolaemia or combined (mixed) dyslipidaemia. Stender S; Budinski D; Gosho M; Hounslow N Eur J Prev Cardiol; 2013 Feb; 20(1):40-53. PubMed ID: 22679249 [TBL] [Abstract][Full Text] [Related]
5. High Tolerability of Pitavastatin Therapy: A Case Report of Comparison with other Statins. Christou GA; Mprikos SG; Christou KA; Christou MA; Christou EA; Nikas DN; Kiortsis DN Cardiology; 2020; 145(7):421-424. PubMed ID: 32160627 [TBL] [Abstract][Full Text] [Related]
6. Intensive statin therapy--a sea change in cardiovascular prevention. Topol EJ N Engl J Med; 2004 Apr; 350(15):1562-4. PubMed ID: 15007111 [No Abstract] [Full Text] [Related]
7. Pitavastatin versus pravastatin in adults with HIV-1 infection and dyslipidaemia (INTREPID): 12 week and 52 week results of a phase 4, multicentre, randomised, double-blind, superiority trial. Aberg JA; Sponseller CA; Ward DJ; Kryzhanovski VA; Campbell SE; Thompson MA Lancet HIV; 2017 Jul; 4(7):e284-e294. PubMed ID: 28416195 [TBL] [Abstract][Full Text] [Related]
9. Statin therapy in chronic heart failure: frog prince or bare frog? Kihara Y Circ J; 2013; 77(4):895-7. PubMed ID: 23502989 [No Abstract] [Full Text] [Related]
10. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. van der Harst P; Voors AA; van Veldhuisen DJ N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15306676 [No Abstract] [Full Text] [Related]
11. [High lowering of lipids can melt coronary plaques -- is coronary disease reversible?]. Einecke D MMW Fortschr Med; 2006 Jun; 148(24):4-5. PubMed ID: 16850796 [No Abstract] [Full Text] [Related]
12. [Statin therapy in patients with acute coronary syndrome. "Prove-it" study]. von Schacky C Internist (Berl); 2004 Dec; 45(12):1437-9. PubMed ID: 15448925 [No Abstract] [Full Text] [Related]
13. [Study of MDA-LDL by pioglitazone and pitavastatin in patients with type 2 diabetes]. Taguchi A; Hayashi S Nihon Rinsho; 2011 Jan; 69(1):100-4. PubMed ID: 21226268 [TBL] [Abstract][Full Text] [Related]
14. C-reactive protein levels and outcomes after statin therapy. Ridker PM; Cannon CP; Morrow D; Rifai N; Rose LM; McCabe CH; Pfeffer MA; Braunwald E; N Engl J Med; 2005 Jan; 352(1):20-8. PubMed ID: 15635109 [TBL] [Abstract][Full Text] [Related]